The Amount of Bifidobacterium Genus in Colorectal Carcinoma Tissue in Relation to Tumor Characteristics and Clinical Outcome

American Journal of Pathology

Volumn 188, Issue 12, 2018, Pages 2839-2852

  Kosumi, Keisuke ^a,b   Hamada, Tsuyoshi ^a   Koh, Hideo ^a,c   Borowsky, Jennifer ^a,d,e,f   Bullman, Susan ^a,g   Twombly, Tyler S ^a   Nevo, Daniel ^h   Masugi, Yohei ^a   Liu, Li ^a,h   da Silva, Annacarolina ^a   Chen, Yang ^a   Du, Chunxia ^a   Gu, Mancang ^a   Li, Chenxi ^a   Li, Wanwan ^a   Liu, Hongli ^a   Shi, Yan ^a   Mima, Kosuke ^a,b   Song, Mingyang ^d,h   Nosho, Katsuhiko ⁱ   Nowak, Jonathan A ^j   Nishihara, Reiko ^a,h,j   Baba, Hideo ^b   Zhang, Xuehong ^j   Wu, Kana ^h,j   Wang, Molin ^h,j   Huttenhower, Curtis ^g,h   Garrett, Wendy S ^a,g,h   Meyerson, Matthew L ^a,g   Lennerz, Jochen K ^d   Giannakis, Marios ^a,g,j   Chan, Andrew T ^d,j   Meyerhardt, Jeffrey A ^a   Fuchs, Charles S ^k,l,m   Ogino, Shuji ^a,g,h,j   more..

^a DANA FARBER CANCER INSTITUTE   (United States)

^b KUMAMOTO UNIVERSITY   (Japan)

^c OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^f UNIVERSITY OF QUEENSLAND   (Australia)

^g BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^h HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j BRIGHAM AND WOMEN S HOSPITAL   (United States)

^k YALE CANCER CENTER   (United States)

^l YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m Smilow Cancer Hospital   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; BIFIDOBACTERIUM DNA; MUCIN; UNCLASSIFIED DRUG; TUMOR MARKER;

ADULT; AGED; ARTICLE; BACTERIUM DETECTION; BIFIDOBACTERIUM; BRAF GENE; CANCER PROGNOSIS; CANCER STAGING; CANCER TISSUE; CELL DENSITY; COLORECTAL CARCINOMA; CPG ISLAND; FEMALE; GENE MUTATION; GENUS; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MORTALITY; NONHUMAN; ONCOGENE; ONCOGENE K RAS; PHENOTYPE; PIK3CA GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIGNET RING CARCINOMA; T LYMPHOCYTE; TUMOR DIFFERENTIATION; TUMOR IMMUNITY; TUMOR LOCALIZATION; VERY ELDERLY; YOUNG ADULT; BIFIDOBACTERIALES INFECTION; COLORECTAL TUMOR; FOLLOW UP; GENETICS; MICROBIOLOGY; MUTATION; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; SURVIVAL RATE; TUMOR MICROENVIRONMENT;

ADULT; AGED; BIFIDOBACTERIALES INFECTIONS; BIFIDOBACTERIUM; BIOMARKERS, TUMOR; CARCINOMA, SIGNET RING CELL; COLORECTAL NEOPLASMS; DNA, BACTERIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MUTATION; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR MICROENVIRONMENT;

EID: 85056764487     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2018.08.015     Document Type: Article

References (78)

1. Dzutsev, A., Badger, J.H., Perez-Chanona, E., Roy, S., Salcedo, R., Smith, C.K., Trinchieri, G., Microbes and cancer. Annu Rev Immunol 35 (2017), 199–228.
2. Honda, K., Littman, D.R., The microbiota in adaptive immune homeostasis and disease. Nature 535 (2016), 75–84.
3. Snyder, A., Pamer, E., Wolchok, J., IMMUNOTHERAPY: could microbial therapy boost cancer immunotherapy?. Science 350 (2015), 1031–1032.
4. Sender, R., Fuchs, S., Milo, R., Revised estimates for the number of human and bacteria cells in the body. PLoS Biol, 14, 2016, e1002533.
5. Gopalakrishnan, V., Spencer, C.N., Nezi, L., Reuben, A., Andrews, M.C., Karpinets, T.V., et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359 (2018), 97–103.
6. Matson, V., Fessler, J., Bao, R., Chongsuwat, T., Zha, Y., Alegre, M.L., Luke, J.J., Gajewski, T.F., The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science 359 (2018), 104–108.
7. Routy, B., Le Chatelier, E., Derosa, L., Duong, C.P.M., Alou, M.T., Daillere, R., et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359 (2018), 91–97.
8. Sears, C.L., Pardoll, D.M., The intestinal microbiome influences checkpoint blockade. Nat Med 24 (2018), 254–255.
9. Dejea, C.M., Fathi, P., Craig, J.M., Boleij, A., Taddese, R., Geis, A.L., Wu, X., DeStefano Shields, C.E., Hechenbleikner, E.M., Huso, D.L., Anders, R.A., Giardiello, F.M., Wick, E.C., Wang, H., Wu, S., Pardoll, D.M., Housseau, F., Sears, C.L., Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria. Science 359 (2018), 592–597.
10. Mima, K., Nishihara, R., Qian, Z.R., Cao, Y., Sukawa, Y., Nowak, J.A., Yang, J., Dou, R., Masugi, Y., Song, M., Kostic, A.D., Giannakis, M., Bullman, S., Milner, D.A., Baba, H., Giovannucci, E.L., Garraway, L.A., Freeman, G.J., Dranoff, G., Garrett, W.S., Huttenhower, C., Meyerson, M., Meyerhardt, J.A., Chan, A.T., Fuchs, C.S., Ogino, S., Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut 65 (2016), 1973–1980.
11. Mima, K., Sukawa, Y., Nishihara, R., Qian, Z.R., Yamauchi, M., Inamura, K., Kim, S.A., Masuda, A., Nowak, J.A., Nosho, K., Kostic, A.D., Giannakis, M., Watanabe, H., Bullman, S., Milner, D.A., Harris, C.C., Giovannucci, E., Garraway, L.A., Freeman, G.J., Dranoff, G., Chan, A.T., Garrett, W.S., Huttenhower, C., Fuchs, C.S., Ogino, S., Fusobacterium nucleatum and T cells in colorectal carcinoma. JAMA Oncol 1 (2015), 653–661.
12. Rajpoot, M., Sharma, A.K., Sharma, A., Gupta, G.K., Understanding the microbiome: emerging biomarkers for exploiting the microbiota for personalized medicine against cancer. Semin Cancer Biol 52:Pt 1 (2018), 1–8.
13. Ogino, S., Galon, J., Fuchs, C.S., Dranoff, G., Cancer immunology: analysis of host and tumor factors for personalized medicine. Nat Rev Clin Oncol 8 (2011), 711–719.
14. Ogino, S., Nowak, J.A., Hamada, T., Phipps, A.I., Peters, U., Milner, D.A. Jr., Giovannucci, E.L., Nishihara, R., Giannakis, M., Garrett, W.S., Song, M., Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine. Gut 67 (2018), 1168–1180.
15. Ogino, S., Nishihara, R., VanderWeele, T.J., Wang, M., Nishi, A., Lochhead, P., Qian, Z.R., Zhang, X., Wu, K., Nan, H., Yoshida, K., Milner, D.A. Jr., Chan, A.T., Field, A.E., Camargo, C.A. Jr., Williams, M.A., Giovannucci, E.L., Review article: the role of molecular pathological epidemiology in the study of neoplastic and non-neoplastic diseases in the era of precision medicine. Epidemiology 27 (2016), 602–611.
16. Masugi, Y., Nishihara, R., Yang, J., Mima, K., da Silva, A., Shi, Y., Inamura, K., Cao, Y., Song, M., Nowak, J.A., Liao, X., Nosho, K., Chan, A.T., Giannakis, M., Bass, A.J., Hodi, F.S., Freeman, G.J., Rodig, S., Fuchs, C.S., Qian, Z.R., Ogino, S., Tumour CD274 (PD-L1) expression and T cells in colorectal cancer. Gut 66 (2017), 1463–1473.
17. Bijlsma, M.F., Sadanandam, A., Tan, P., Vermeulen, L., Molecular subtypes in cancers of the gastrointestinal tract. Nat Rev Gastroenterol Hepatol 14 (2017), 333–342.
18. Naxerova, K., Reiter, J.G., Brachtel, E., Lennerz, J.K., van de Wetering, M., Rowan, A., Cai, T., Clevers, H., Swanton, C., Nowak, M.A., Elledge, S.J., Jain, R.K., Origins of lymphatic and distant metastases in human colorectal cancer. Science 357 (2017), 55–60.
19. Li, H., Courtois, E.T., Sengupta, D., Tan, Y., Chen, K.H., Goh, J.J.L., Kong, S.L., Chua, C., Hon, L.K., Tan, W.S., Wong, M., Choi, P.J., Wee, L.J.K., Hillmer, A.M., Tan, I.B., Robson, P., Prabhakar, S., Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors. Nat Genet 49 (2017), 708–718.
20. Ogino, S., Jhun, I., Mata, D.A., Soong, T.R., Hamada, T., Liu, L., Nishihara, R., Giannakis, M., Cao, Y., Manson, J.E., Nowak, J.A., Chan, A.T., Integration of pharmacology, molecular pathology, and population data science to support precision gastrointestinal oncology. NPJ Precis Oncol, 1, 2017, 40.
21. Gagliani, N., Hu, B., Huber, S., Elinav, E., Flavell, R.A., The fire within: microbes inflame tumors. Cell 157 (2014), 776–783.
22. Fukuda, S., Toh, H., Hase, K., Oshima, K., Nakanishi, Y., Yoshimura, K., Tobe, T., Clarke, J.M., Topping, D.L., Suzuki, T., Taylor, T.D., Itoh, K., Kikuchi, J., Morita, H., Hattori, M., Ohno, H., Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469 (2011), 543–547.
23. Laforest-Lapointe, I., Arrieta, M.C., Patterns of early-life gut microbial colonization during human immune development: an ecological perspective. Front Immunol, 8, 2017, 788.
24. Ubeda, C., Djukovic, A., Isaac, S., Roles of the intestinal microbiota in pathogen protection. Clin Transl Immunology, 6, 2017, e128.
25. Becker, S., Oelschlaeger, T.A., Wullaert, A., Vlantis, K., Pasparakis, M., Wehkamp, J., Stange, E.F., Gersemann, M., Bacteria regulate intestinal epithelial cell differentiation factors both in vitro and in vivo. PLoS One, 8, 2013, e55620.
26. Wolnerhanssen, B.K., Moran, A.W., Burdyga, G., Meyer-Gerspach, A.C., Peterli, R., Manz, M., Thumshirn, M., Daly, K., Beglinger, C., Shirazi-Beechey, S.P., Deregulation of transcription factors controlling intestinal epithelial cell differentiation: a predisposing factor for reduced enteroendocrine cell number in morbidly obese individuals. Sci Rep, 7, 2017, 8174.
27. Sivan, A., Corrales, L., Hubert, N., Williams, J.B., Aquino-Michaels, K., Earley, Z.M., Benyamin, F.W., Lei, Y.M., Jabri, B., Alegre, M.L., Chang, E.B., Gajewski, T.F., Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 350 (2015), 1084–1089.
28. Mlecnik, B., Bindea, G., Angell, H.K., Maby, P., Angelova, M., Tougeron, D., Church, S.E., Lafontaine, L., Fischer, M., Fredriksen, T., Sasso, M., Bilocq, A.M., Kirilovsky, A., Obenauf, A.C., Hamieh, M., Berger, A., Bruneval, P., Tuech, J.J., Sabourin, J.C., Le Pessot, F., Mauillon, J., Rafii, A., Laurent-Puig, P., Speicher, M.R., Trajanoski, Z., Michel, P., Sesboue, R., Frebourg, T., Pages, F., Valge-Archer, V., Latouche, J.B., Galon, J., Integrative analyses of colorectal cancer show immunoscore is a stronger predictor of patient survival than microsatellite instability. Immunity 44 (2016), 698–711.
29. Giannakis, M., Mu, X.J., Shukla, S.A., Qian, Z.R., Cohen, O., Nishihara, R., Bahl, S., Cao, Y., Amin-Mansour, A., Yamauchi, M., Sukawa, Y., Stewart, C., Rosenberg, M., Mima, K., Inamura, K., Nosho, K., Nowak, J.A., Lawrence, M.S., Giovannucci, E.L., Chan, A.T., Ng, K., Meyerhardt, J.A., Van Allen, E.M., Getz, G., Gabriel, S.B., Lander, E.S., Wu, C.J., Fuchs, C.S., Ogino, S., Garraway, L.A., Genomic correlates of immune-cell infiltrates in colorectal carcinoma. Cell Rep 15 (2016), 857–865.
30. Nosho, K., Baba, Y., Tanaka, N., Shima, K., Hayashi, M., Meyerhardt, J.A., Giovannucci, E., Dranoff, G., Fuchs, C.S., Ogino, S., Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review. J Pathol 222 (2010), 350–366.
31. Ogino, S., Nosho, K., Irahara, N., Meyerhardt, J.A., Baba, Y., Shima, K., Glickman, J.N., Ferrone, C.R., Mino-Kenudson, M., Tanaka, N., Dranoff, G., Giovannucci, E.L., Fuchs, C.S., Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype. Clin Cancer Res 15 (2009), 6412–6420.
32. Ogino, S., Giannakis, M., Immunoscore for (colorectal) cancer precision medicine. Lancet 391 (2018), 2084–2086.
33. Pages, F., Mlecnik, B., Marliot, F., Bindea, G., Ou, F.S., Bifulco, C., et al. International validation of the consensus immunoscore for the classification of colon cancer: a prognostic and accuracy study. Lancet 391 (2018), 2128–2139.
34. Nishihara, R., Wu, K., Lochhead, P., Morikawa, T., Liao, X., Qian, Z.R., Inamura, K., Kim, S.A., Kuchiba, A., Yamauchi, M., Imamura, Y., Willett, W.C., Rosner, B.A., Fuchs, C.S., Giovannucci, E., Ogino, S., Chan, A.T., Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med 369 (2013), 1095–1105.
35. Yamauchi, M., Morikawa, T., Kuchiba, A., Imamura, Y., Qian, Z.R., Nishihara, R., Liao, X., Waldron, L., Hoshida, Y., Huttenhower, C., Chan, A.T., Giovannucci, E., Fuchs, C., Ogino, S., Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum. Gut 61 (2012), 847–854.
36. Mima, K., Cao, Y., Chan, A.T., Qian, Z.R., Nowak, J.A., Masugi, Y., Shi, Y., Song, M., da Silva, A., Gu, M., Li, W., Hamada, T., Kosumi, K., Hanyuda, A., Liu, L., Kostic, A.D., Giannakis, M., Bullman, S., Brennan, C.A., Milner, D.A., Baba, H., Garraway, L.A., Meyerhardt, J.A., Garrett, W.S., Huttenhower, C., Meyerson, M., Giovannucci, E.L., Fuchs, C.S., Nishihara, R., Ogino, S., Fusobacterium nucleatum in colorectal carcinoma tissue according to tumor location. Clin Transl Gastroenterol, 7, 2016, e200.
37. Inamura, K., Yamauchi, M., Nishihara, R., Kim, S.A., Mima, K., Sukawa, Y., Li, T., Yasunari, M., Zhang, X., Wu, K., Meyerhardt, J.A., Fuchs, C.S., Harris, C.C., Qian, Z.R., Ogino, S., Prognostic significance and molecular features of signet-ring cell and mucinous components in colorectal carcinoma. Ann Surg Oncol 22 (2015), 1226–1235.
38. Bosman, F.T. World Health Organization, International Agency for Research on Cancer. WHO Classification of Tumours of the Digestive System. ed 4., 2010, International Agency for Research on Cancer, Lyon.
39. Furet, J.P., Firmesse, O., Gourmelon, M., Bridonneau, C., Tap, J., Mondot, S., Dore, J., Corthier, G., Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR. FEMS Microbiol Ecol 68 (2009), 351–362.
40. Sobhani, I., Tap, J., Roudot-Thoraval, F., Roperch, J.P., Letulle, S., Langella, P., Corthier, G., Tran Van Nhieu, J., Furet, J.P., Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One, 6, 2011, e16393.
41. Schmittgen, T.D., Livak, K.J., Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3 (2008), 1101–1108.
42. Ogino, S., Nosho, K., Kirkner, G.J., Kawasaki, T., Meyerhardt, J.A., Loda, M., Giovannucci, E.L., Fuchs, C.S., CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut 58 (2009), 90–96.
43. Imamura, Y., Lochhead, P., Yamauchi, M., Kuchiba, A., Qian, Z.R., Liao, X., Nishihara, R., Jung, S., Wu, K., Nosho, K., Wang, Y.E., Peng, S., Bass, A.J., Haigis, K.M., Meyerhardt, J.A., Chan, A.T., Fuchs, C.S., Ogino, S., Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review. Mol Cancer, 13, 2014, 135.
44. Liao, X., Lochhead, P., Nishihara, R., Morikawa, T., Kuchiba, A., Yamauchi, M., Imamura, Y., Qian, Z.R., Baba, Y., Shima, K., Sun, R., Nosho, K., Meyerhardt, J.A., Giovannucci, E., Fuchs, C.S., Chan, A.T., Ogino, S., Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. N Engl J Med 367 (2012), 1596–1606.
45. Chan, A.T., Ogino, S., Fuchs, C.S., Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med 356 (2007), 2131–2142.
46. Morikawa, T., Kuchiba, A., Yamauchi, M., Meyerhardt, J.A., Shima, K., Nosho, K., Chan, A.T., Giovannucci, E., Fuchs, C.S., Ogino, S., Association of CTNNB1 (beta-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer. JAMA 305 (2011), 1685–1694.
47. Chan, A.T., Ogino, S., Fuchs, C.S., Aspirin use and survival after diagnosis of colorectal cancer. JAMA 302 (2009), 649–658.
48. Benjamin, D.J., Berger, J.O., Johannesson, M., Nosek, B.A., Wagenmakers, E.J., Berk, R., et al. Redefine statistical significance. Nat Hum Behav 2 (2018), 6–10.
49. Ioannidis, J.P., How to make more published research true. PLoS Med, 11, 2014, e1001747.
50. Hamada, T., Cao, Y., Qian, Z.R., Masugi, Y., Nowak, J.A., Yang, J., Song, M., Mima, K., Kosumi, K., Liu, L., Shi, Y., da Silva, A., Gu, M., Li, W., Keum, N., Zhang, X., Wu, K., Meyerhardt, J.A., Giovannucci, E.L., Giannakis, M., Rodig, S.J., Freeman, G.J., Nevo, D., Wang, M., Chan, A.T., Fuchs, C.S., Nishihara, R., Ogino, S., Aspirin use and colorectal cancer survival according to tumor CD274 (programmed cell death 1 ligand 1) expression status. J Clin Oncol 35 (2017), 1836–1844.
51. Liu, L., Nevo, D., Nishihara, R., Cao, Y., Song, M., Twombly, T.S., Chan, A.T., Giovannucci, E.L., VanderWeele, T.J., Wang, M., Ogino, S., Utility of inverse probability weighting in molecular pathological epidemiology. Eur J Epidemiol 33 (2018), 381–392.
52. Seaman, S.R., White, I.R., Review of inverse probability weighting for dealing with missing data. Stat Methods Med Res 22 (2013), 278–295.
53. Xie, J., Liu, C., Adjusted Kaplan-Meier estimator and log-rank test with inverse probability of treatment weighting for survival data. Stat Med 24 (2005), 3089–3110.
54. Hu, Y., Le Leu, R.K., Christophersen, C.T., Somashekar, R., Conlon, M.A., Meng, X.Q., Winter, J.M., Woodman, R.J., McKinnon, R., Young, G.P., Manipulation of the gut microbiota using resistant starch is associated with protection against colitis-associated colorectal cancer in rats. Carcinogenesis 37 (2016), 366–375.
55. O'Callaghan, A., van Sinderen, D., Bifidobacteria and their role as members of the human gut microbiota. Front Microbiol, 7, 2016, 925.
56. Alvi, M.A., Loughrey, M.B., Dunne, P., McQuaid, S., Turkington, R., Fuchs, M.A., McGready, C., Bingham, V., Pang, B., Moore, W., Maxwell, P., Lawler, M., James, J.A., Murray, G.I., Wilson, R.H., Salto-Tellez, M., Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapies. Br J Cancer 117 (2017), 203–209.
57. Liang, Z., Yan, D., Li, G., Cheng, H., Clinical analysis of primary colorectal signet-ring cell carcinoma. Clin Colorectal Cancer 17 (2018), e39–e44.
58. Razenberg, L.G., van Gestel, Y.R., Lemmens, V.E., de Wilt, J.H., Creemers, G.J., de Hingh, I.H., The prognostic relevance of histological subtype in patients with peritoneal metastases from colorectal cancer: a nationwide population-based study. Clin Colorectal Cancer 14 (2015), e13–e19.
59. Ogino, S., Brahmandam, M., Cantor, M., Namgyal, C., Kawasaki, T., Kirkner, G., Meyerhardt, J.A., Loda, M., Fuchs, C.S., Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component. Mod Pathol 19 (2006), 59–68.
60. Kong, X., Zhang, X., Huang, Y., Tang, L., Peng, Q., Li, J., Characteristics and prognostic factors of colorectal mucinous adenocarcinoma with signet ring cells. Cancer Manag Res 9 (2017), 573–580.
61. Schneider, G., Schmidt-Supprian, M., Rad, R., Saur, D., Tissue-specific tumorigenesis: context matters. Nat Rev Cancer 17 (2017), 239–253.
62. Tsilimigras, M.C., Fodor, A., Jobin, C., Carcinogenesis and therapeutics: the microbiota perspective. Nat Microbiol, 2, 2017, 17008.
63. White, K.A., Grillo-Hill, B.K., Barber, D.L., Cancer cell behaviors mediated by dysregulated pH dynamics at a glance. J Cell Sci 130 (2017), 663–669.
64. Brand, A., Singer, K., Koehl, G.E., Kolitzus, M., Schoenhammer, G., Thiel, A., et al. LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells. Cell Metab 24 (2016), 657–671.
65. Dart, A., Tumour metabolism: lactic acid: not just a waste product?. Nat Rev Cancer 16 (2016), 676–677.
66. Colegio, O.R., Chu, N.Q., Szabo, A.L., Chu, T., Rhebergen, A.M., Jairam, V., Cyrus, N., Brokowski, C.E., Eisenbarth, S.C., Phillips, G.M., Cline, G.W., Phillips, A.J., Medzhitov, R., Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 513 (2014), 559–563.
67. Schug, Z.T., Vande Voorde, J., Gottlieb, E., The metabolic fate of acetate in cancer. Nat Rev Cancer 16 (2016), 708–717.
68. Schug, Z.T., Peck, B., Jones, D.T., Zhang, Q., Grosskurth, S., Alam, I.S., Goodwin, L.M., Smethurst, E., Mason, S., Blyth, K., McGarry, L., James, D., Shanks, E., Kalna, G., Saunders, R.E., Jiang, M., Howell, M., Lassailly, F., Thin, M.Z., Spencer-Dene, B., Stamp, G., van den Broek, N.J., Mackay, G., Bulusu, V., Kamphorst, J.J., Tardito, S., Strachan, D., Harris, A.L., Aboagye, E.O., Critchlow, S.E., Wakelam, M.J., Schulze, A., Gottlieb, E., Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress. Cancer Cell 27 (2015), 57–71.
69. Routy, B., Gopalakrishnan, V., Daillere, R., Zitvogel, L., Wargo, J.A., Kroemer, G., The gut microbiota influences anticancer immunosurveillance and general health. Nat Rev Clin Oncol 15 (2018), 382–396.
70. Taniguchi, S., Shimatani, Y., Fujimori, M., Tumor-targeting therapy using gene-engineered anaerobic-nonpathogenic Bifidobacterium longum. Methods Mol Biol 1409 (2016), 49–60.
71. Lehouritis, P., Stanton, M., McCarthy, F.O., Jeavons, M., Tangney, M., Activation of multiple chemotherapeutic prodrugs by the natural enzymolome of tumour-localised probiotic bacteria. J Control Release 222 (2016), 9–17.
72. Kikuchi, T., Shimizu, H., Akiyama, Y., Taniguchi, S., In situ delivery and production system of trastuzumab scFv with Bifidobacterium. Biochem Biophys Res Commun 493 (2017), 306–312.
73. Tjalsma, H., Boleij, A., Marchesi, J.R., Dutilh, B.E., A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat Rev Microbiol 10 (2012), 575–582.
74. Meyerhardt, J.A., Mayer, R.J., Systemic therapy for colorectal cancer. N Engl J Med 352 (2005), 476–487.
75. Hamada, T., Keum, N., Nishihara, R., Ogino, S., Molecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis. J Gastroenterol 52 (2017), 265–275.
76. Loree, J.M., Bailey, A.M., Johnson, A.M., Yu, Y., Wu, W., Bristow, C.A., Davis, J.S., Shaw, K.R., Broaddus, R., Banks, K.C., Lanman, R.B., Meric-Bernstam, F., Overman, M.J., Kopetz, S., Raghav, K., Molecular landscape of ERBB2/ERBB3 mutated colorectal cancer. J Natl Cancer Inst, 2018 [Epub ahead of print] doi: 10.1093/jnci/djy067.
77. Loree, J.M., Pereira, A.A.L., Lam, M., Willauer, A.N., Raghav, K., Dasari, A., Morris, V.K., Advani, S., Menter, D.G., Eng, C., Shaw, K., Broaddus, R., Routbort, M.J., Liu, Y., Morris, J.S., Luthra, R., Meric-Bernstam, F., Overman, M.J., Maru, D., Kopetz, S., Classifying colorectal cancer by tumor location rather than sidedness highlights a continuum in mutation profiles and consensus molecular subtypes. Clin Cancer Res 24 (2018), 1062–1072.
78. Domingo, E., Camps, C., Kaisaki, P.J., Parsons, M.J., Mouradov, D., Pentony, M.M., Makino, S., Palmieri, M., Ward, R.L., Hawkins, N.J., Gibbs, P., Askautrud, H., Oukrif, D., Wang, H., Wood, J., Tomlinson, E., Bark, Y., Kaur, K., Johnstone, E.C., Palles, C., Church, D.N., Novelli, M., Danielsen, H.E., Sherlock, J., Kerr, D., Kerr, R., Sieber, O., Taylor, J.C., Tomlinson, I., Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series. Lancet Gastroenterol Hepatol 3 (2018), 635–643.